Expression of nine tumour antigens in a series of human glioblastoma multiforme: interest of EGFRvIII, IL-13Ralpha2, gp100 and TRP-2 for immunotherapy
/in Glioblastoma, International Publications /von 2006-09-27 / J. Neurooncol. 2007 Jan;81(2):139-48Radiochemotherapy combined with regional pelvic hyperthermia induces high response and resectability rates in patients with nonresectable cervical cancer > or =FIGO IIB „bulky“
/in Cervical Cancer, International Publications /von 2006-09-18 / Int. J. Radiat. Oncol. Biol. Phys. 2006 Nov;66(4):1159-67Noninvasive magnetic resonance thermography of soft tissue sarcomas during regional hyperthermia: correlation with response and direct thermometry
/in Hyperthermia, International Publications, Soft Tissue Sarcoma /von 2006-09-15 / Cancer 2006 Sep;107(6):1373-82Patient-specific dendritic-cell vaccines for metastatic melanoma
/in International Publications, Malignant Melanoma /von 2006-09-14 / N. Engl. J. Med. 2006 Sep;355(11):1179-81Heat shock treatment of tumor lysate-pulsed dendritic cells enhances their capacity to elicit antitumor T cell responses against medullary thyroid carcinoma
/in Dendritic Cells, International Publications, Thyroid Cancer /von 2006-09-05 / J. Clin. Endocrinol. Metab. 2006 Nov;91(11):4571-7Successful immunological treatment of gallbladder cancer in India–case report
/in Dendritic Cells, Gallbladder Cancer, International Publications /von 2006-09-01 / J Zhejiang Univ Sci B 2006 Sep;7(9):719-24Apoptotic, necrotic, or fused tumor cells: an equivalent source of antigen for dendritic cell loading
/in Colorectal Cancer, International Publications /von 2006-09-01 / Apoptosis 2006 Sep;11(9):1513-24Dendritic cell-based immunotherapy
/in Dendritic Cells, International Publications /von 2006-09-01 / Int. Rev. Immunol. 2006 Sep-Dec;25(5-6):377-413Induction of potent antitumor immunity by intratumoral injection of interleukin 23-transduced dendritic cells
/in Glioblastoma, International Publications /von 2006-09-01 / Cancer Res. 2006 Sep;66(17):8887-96
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de